Principal Financial Group
SCMP

Principal Financial Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Principal Financial Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-188,451
Closed -$3.38M – 2280
2017
Q4 		$3.38M Sell
188,451
-1,123
-0.6% -$13.8K ﹤0.01% 1669
2017
Q3 		$2.24M Sell
189,574
-1,271
-0.7% -$14.3K ﹤0.01% 1720
2017
Q2 		$2M Buy
190,845
+2,712
+1% +$27.6K ﹤0.01% 1741
2017
Q1 		$2.07M Buy
+188,133
New +$2.18M ﹤0.01% 1722

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Principal Financial Group's SCMP Position: Q1 2018 in Review

Principal Financial Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 188,451 shares — an estimated $3.38M sold.

Principal Financial Group first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $3.38M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Principal Financial Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Principal Financial Group sold 188,451 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.38M.
  • Principal Financial Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Principal Financial Group's Sucampo Pharmaceuticals, Inc. position peaked at $3.38M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Principal Financial Group's 13F filing for Q1 2018, filed 14 May 2018.